BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cannavo A, Koch WJ. GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease. Cell Signal 2018;41:33-40. [PMID: 28077324 DOI: 10.1016/j.cellsig.2017.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Luttrell LM, Premont RT, Rockey DC. β-Arrestin2 is a critical component of the GPCR-eNOS signalosome. Proc Natl Acad Sci U S A 2020;117:11483-92. [PMID: 32404425 DOI: 10.1073/pnas.1922608117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
2 Snyder J, Lackey AI, Brown GS, Diaz M, Yuzhen T, Sato PY. GRK2 contributes to glucose mediated calcium responses and insulin secretion in pancreatic islet cells. Sci Rep 2021;11:11129. [PMID: 34045505 DOI: 10.1038/s41598-021-90253-z] [Reference Citation Analysis]
3 Penela P, Inserte J, Ramos P, Rodriguez-Sinovas A, Garcia-Dorado D, Mayor F Jr. Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion. EBioMedicine 2019;48:605-18. [PMID: 31594751 DOI: 10.1016/j.ebiom.2019.09.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
4 Cannavo A, Komici K, Bencivenga L, D'amico ML, Gambino G, Liccardo D, Ferrara N, Rengo G. GRK2 as a therapeutic target for heart failure. Expert Opin Ther Targets 2018;22:75-83. [PMID: 29166798 DOI: 10.1080/14728222.2018.1406925] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
5 Penela P, Ribas C, Sánchez-Madrid F, Mayor F Jr. G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub. Cell Mol Life Sci 2019;76:4423-46. [PMID: 31432234 DOI: 10.1007/s00018-019-03274-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
6 Kayki-Mutlu G, Koch WJ. Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets. Int J Mol Sci 2021;22:E521. [PMID: 33430208 DOI: 10.3390/ijms22020521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Murga C, Arcones AC, Cruces-Sande M, Briones AM, Salaices M, Mayor F Jr. G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases. Front Pharmacol 2019;10:112. [PMID: 30837878 DOI: 10.3389/fphar.2019.00112] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
8 Grisanti LA, Schumacher SM, Tilley DG, Koch WJ. Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease. JACC Basic Transl Sci 2018;3:550-62. [PMID: 30175279 DOI: 10.1016/j.jacbts.2017.12.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
9 Zhai R, Snyder J, Montgomery S, Sato PY. Double life: How GRK2 and β-arrestin signaling participate in diseases. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110333] [Reference Citation Analysis]
10 Arosio B, Corbi G, Davinelli S, Giordano V, Liccardo D, Rapacciuolo A, Cannavo A. Sex Differences in Cardiovascular Diseases: A Matter of Estrogens, Ceramides, and Sphingosine 1-Phosphate. Int J Mol Sci 2022;23:4009. [PMID: 35409368 DOI: 10.3390/ijms23074009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Akintunde JK, Akintola TE, Hammed MO, Amoo CO, Adegoke AM, Ajisafe LO. Naringin protects against Bisphenol-A induced oculopathy as implication of cataract in hypertensive rat model. Biomed Pharmacother 2020;126:110043. [PMID: 32172062 DOI: 10.1016/j.biopha.2020.110043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Cannavo A, Liccardo D, Komici K, Corbi G, de Lucia C, Femminella GD, Elia A, Bencivenga L, Ferrara N, Koch WJ, Paolocci N, Rengo G. Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System. Front Pharmacol 2017;8:556. [PMID: 28878674 DOI: 10.3389/fphar.2017.00556] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]